Q&A With Alex Thompson From St. Vincent's Hospital: Developing New Treatments For Genotype 3 Hepatitis C Patients

Video

It may be the second most common genotype of hepatitis C but for patients diagnosed with genotype 3 it is also proving to be considerably harder to treat than genotype 1 which has a cure rate near 90%.

It may be the second most common genotype of hepatitis C but for patients diagnosed with genotype 3 it is also proving to be considerably harder to treat than genotype 1 which has a cure rate near 90%.

Alex Thompson, MBBS, PhD, from St. Vincent's Hospital in Melbourne Australia discussed what work is being done for patients with this genotype and others for future treatment of the disease.

Related Videos
Andrew Talal, MD | Credit: University at Buffalo
Andrew Talal, MD | Credit: University at Buffalo
Square thumbnail featuring headshots of Gursimran Kochhar, MD; Frank Colangelo, MD; Thomas Imperiale, MD; and Michael Sapienza
Square thumbnail featuring headshots of Gursimran Kochhar, MD; Frank Colangelo, MD; Thomas Imperiale, MD; and Michael Sapienza
Square thumbnail featuring headshots of Gursimran Kochhar, MD; Frank Colangelo, MD; Thomas Imperiale, MD; and Michael Sapienza
Square thumbnail featuring headshots of Gursimran Kochhar, MD; Frank Colangelo, MD; Thomas Imperiale, MD; and Michael Sapienza
Square thumbnail featuring headshots of Gursimran Kochhar, MD; Frank Colangelo, MD; Thomas Imperiale, MD; and Michael Sapienza
Taha Qazi, MD | Credit: Cleveland Clinic
Taha Qazi, MD | Credit: Cleveland Clinic
Taha Qazi, MD | Cleveland Clinic
© 2024 MJH Life Sciences

All rights reserved.